Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evaxion Biotech A/S

1.65
+0.06003.77%
Post-market: 1.700.0500+3.03%19:58 EDT
Volume:59.80K
Turnover:97.98K
Market Cap:10.34M
PE:-0.17
High:1.70
Open:1.59
Low:1.59
Close:1.59
Loading ...

European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading

MT Newswires Live
·
17 Dec 2024

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down 1.5% for Week

MT Newswires Live
·
14 Dec 2024

Evaxion Biotech Advances AI-Driven Precision Cancer Vaccine Concept

TIPRANKS
·
12 Dec 2024

Evaxion Biotech establishes new Ai-derived precision cancer vaccine concept

TIPRANKS
·
12 Dec 2024

Evaxion establishes new AI-derived precision cancer vaccine concept

GlobeNewswire
·
12 Dec 2024

European Equities Traded in the US as American Depositary Lower in Tuesday Trading

MT Newswires Live
·
11 Dec 2024

Evaxion announces 2025 milestones reflecting continued strong strategy execution

GlobeNewswire
·
09 Dec 2024

European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading

MT Newswires Live
·
05 Dec 2024

Evaxion Biotech Unveils Precision Cancer Vaccine Breakthrough

TIPRANKS
·
03 Dec 2024

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
03 Dec 2024

Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress

GlobeNewswire
·
02 Dec 2024

European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week

MT Newswires Live
·
16 Nov 2024

ADRs End Lower; Evaxion Biotech A/S Declines 26%

Dow Jones
·
14 Nov 2024

Evaxion Biotech Appeals Nasdaq Delisting Decision

TIPRANKS
·
13 Nov 2024

Evaxion Receives and Appeals Delisting Determination From Nasdaq, Remains Committed to Nasdaq Listing

THOMSON REUTERS
·
13 Nov 2024

Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing

GlobeNewswire
·
13 Nov 2024

Evaxion Biotech Advances CMV Vaccine with AI Innovation

TIPRANKS
·
13 Nov 2024

European Equities Traded in the US as American Depositary Fall Sharply in Tuesday Trading

MT Newswires Live
·
13 Nov 2024

EVAX Racks up Positive Test Results

Zacks Small Cap Research
·
12 Nov 2024

BRIEF-Evaxion Announces Positive Preclinical Data For Cytomegalovirus Vaccine Program EVX-V1

Reuters
·
12 Nov 2024